Mini-Tumors in a dish may guide cancer treatment choices

NCT ID NCT06686342

Recruiting now Knowledge-focused Sponsor: Huashan Hospital Source: ClinicalTrials.gov ↗

First seen Sep 30, 2025 · Last updated Jun 13, 2026 · Updated 35 times

Summary

This study looks at whether tiny lab-grown copies of a patient's tumor (called organoids) can predict which drugs will work best for that person. Researchers will compare the organoid test results with how the patient actually responds to treatment. The goal is to see if this approach can help doctors choose more effective therapies for people with recurrent or metastatic head and neck squamous cell carcinoma.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for HEAD AND NECK SQUAMOUS CELL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Study contacts

Contact

Phone: •••-•••-•••• Email: •••••@•••••
Contact

Phone: •••-•••-•••• Email: •••••@•••••

Locations

Huashan Hospital, Fudan University
ACTIVE_NOT_RECRUITING

Shanghai, Shanghai Municipality, 200040, China
Huashan Hospital, Fudan University
RECRUITING

Shanghai, Shanghai Municipality, 200040, China

Contact Phone: •••-•••-•••• Email: •••••@•••••

Contact Phone: •••-•••-•••• Email: •••••@•••••

Conditions

Explore the condition pages connected to this study.

DRUG SENSITIVE TEST IN VITRO HEAD AND NECK SQUAMOUS CELL CARCINOMA HEAD AND NECK SQUAMOUS CELL CARCINOMA PATIENT DERIVED ORGANOID